Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000721748-13-000770
Filing Date
2013-11-13
Accepted
2013-11-13 10:54:12
Documents
9
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 mspc10q0930full.htm 10-Q 134159
8 EXHIBIT 31.1 mspcex311.htm EX-31.1 8079
9 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION mspcex321.htm EX-32.1 2944
  Complete submission text file 0000721748-13-000770.txt   1227174

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE FILE mspc-20130930.xml EX-101.INS 75940
3 XBRL SCHEMA FILE mspc-20130930.xsd EX-101.SCH 17086
4 XBRL CALCULATION FILE mspc-20130930_cal.xml EX-101.CAL 20287
5 XBRL DEFINITION FILE mspc-20130930_def.xml EX-101.DEF 24883
6 XBRL LABEL FILE mspc-20130930_lab.xml EX-101.LAB 95681
7 XBRL PRESENTATION FILE mspc-20130930_pre.xml EX-101.PRE 83919
Mailing Address 888 BRICKELL KEY DR. UNIT 1102 MIAMI FL 33131
Business Address 888 BRICKELL KEY DR. UNIT 1102 MIAMI FL 33131 3056000407
METROSPACES, INC. (Filer) CIK: 0001488501 (see all company filings)

EIN.: 000000000 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-166237 | Film No.: 131213178
SIC: 2835 In Vitro & In Vivo Diagnostic Substances